Piramal Pharma to Invest USD 90 Million in Expanding US FacilitiesMumbai-based Piramal Pharma Limited has made a USD 90 million investment to build out two of its facilities in the US. The announcement comes on the backdrop of the 2025 Select USA...
P. D. Hinduja Hospital & Medical Research Centre, in collaboration with the Hinduja Foundation, today expanded its groundbreaking Type 1 Diabetes Initiative.
Cyberabad police arrested the former CEO of a prominent corporate hospital in Mumbai, caught with 53 grams of cocaine, who was heavily addicted to drugs.
U.S. President Donald Trump’s latest administrative order pointing to cut domestic drug prices could wave across global pharmaceutical markets, with certain pressure on India to raise prices.
Emcutix Biopharmaceuticals Ltd., in collaboration with Canada-based Mantra Pharma Inc. – both subsidiaries of Emcure Pharmaceuticals Ltd. – has announced the pan-India launch of Ureaderm 10 percent & 20 percent, a urea-based moisturizer in cream
India Eyes Kuwait Pharma Market Amid Growing Import DemandIn a bid to tap into increasing pharmaceutical demand in Kuwait, the Indian Pharmaceuticals Export Promotion Council of India (Pharmexcil) is seeking comments from Indian pharma...
India’s pharmaceutical sector is feeling the heat after U.S. President Donald Trump unveiled a bold plan to cut drug prices by 30-80%. This policy, aimed at making U.S. drug costs match lower prices in other countries, could shake up the 9 billio...
Solara Active Pharma Sciences reported that its Ambernath facility in Maharashtra, having multiple products manufacturing, passed inspection by the United States Food and Drug Administration (USFDA)...
The Centre's latest move to impose a ban on the export of pharmaceuticals to Pakistan, after the April 22 terror attack in Pahalgam, which killed 26 people, will have negligible or no effect on Himachal Pradesh's pharmaceutical industry...
A report from the Drugs Technical Advisory Board's (DTAB) subcommittee, led by Dr. Nilima Kshirsagar, found 16 fixed dose combinations (FDCs) to be irrational and suggested that they be banned because they could endanger human health. The DTAB concur
, CDSCO.jpg)
